Abraham Ceesay's Net Worth
$2.06 Million
Who is Abraham Ceesay?
Abraham Ceesay has an estimated net worth of $2.06 Million. This is based on reported shares across multiple companies, which include Cerevel Therapeutics Holdings, Inc., scPharmaceuticals Inc., Pacira BioSciences, Inc., and Rapport Therapeutics, Inc..
SEC CIK
Abraham Ceesay's CIK is 0001722140
Past Insider Trading and Trends
2022 was Abraham Ceesay's most active year for acquiring shares with 6 total transactions. Abraham Ceesay's most active month to acquire stocks was the month of May. 2022 was Abraham Ceesay's most active year for disposing of shares, totalling 11 transactions. Abraham Ceesay's most active month to dispose stocks was the month of July. 2022 saw Abraham Ceesay paying a total of $1,265,057.52 for 216,366 shares, this is the most they've acquired in one year. In 2022 Abraham Ceesay cashed out on 192,112 shares for a total of $3,255,048.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cerevel Therapeutics Holdings, Inc. (CERE) No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
$22.84 | -$371,329.30 |
0
|
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$22.84 | -$185,664.65 |
0
|
Scheduled
|
Aug 22
| ||
Form 4
|
—
|
0
|
$23.65 | -$201,245.70 |
0
|
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
$23.86 | -$1,231,751.05 |
0
|
Scheduled
|
Aug 5 - Aug 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
scPharmaceuticals Inc. (SCPH) Snapshot price: $5.3
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira BioSciences, Inc. (PCRX) Snapshot price: $13.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.23K |
—
|
—
| 5.23K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rapport Therapeutics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||